Induction chemotherapy with carboplatin, irinotecan, and paclitaxel followed by high dose three-dimension conformal thoracic radiotherapy (74 Gy) with concurrent carboplatin, paclitaxel, and gefitinib in unresectable stage IIIA and stage IIIB non-small cell lung cancer Article

cited authors

  • Stinchcombe, Thomas E.; Morris, David E.; Lee, Carrie B.; Moore, Dominic T.; Hayes, D. Neil; Halle, Jan S.; Rivera, M. Patricia; Rosenman, Julian G.; Socinski, Mark A.

authors

Publication Date

  • March 1, 2008

webpage

published in

category

keywords

  • combined modality therapy
  • concurrent chemoradiotherapy
  • conformal radiation therapy
  • epidermal growth factor receptor
  • high-dose radiation
  • tyrosine kinase inhibitor

start page

  • 250

end page

  • 257

volume

  • 3

issue

  • 3